◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

INSIGHT MOLECULAR DIAGNOSTICS INC.

CIK: 1642380 SIC: 2835
$4.40M
Revenue
$-60.78M
Net Income
54.73%
Gross Margin
-1392.91%
Op. Margin
$-42.87M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 13 of 30 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $260.00K $518.00K $2.14M $1.49M $115.00K $104.00K $176.00K $314.00K $429.00K $463.00K $297.00K $-3.55M $1.02M
Revenue Growth % (YoY) 126.1% 398.1% 1114.8% 373.2% -73.2% -77.5% -40.7% 108.8% -57.8% nan% nan% nan% nan%
Cost of Revenue $121.00K $168.00K $806.00K $869.00K $43.00K $32.00K $252.00K $409.00K $159.00K $169.00K $265.00K $-2.76M $1.22M
+ Gross Profit $139.00K $350.00K $1.32M $595.00K $50.00K $50.00K $-98.00K $-117.00K $248.00K $272.00K $10.00K $2.00M $-1.17M
Gross Margin % 53.5% 67.6% 62.0% 40.0% 43.5% 48.1% -55.7% -37.3% 57.8% 58.7% 3.4% -56.4% -115.4%
Operating Expenses $11.19M $10.19M $8.12M $34.22M $13.56M $4.68M $9.17M $16.06M $6.76M $8.57M $-5.84M $-7.68M $8.05M
Research & Development $3.88M $3.28M $2.92M $2.26M $2.82M $2.45M $2.17M $2.55M $2.19M $2.44M $2.13M $-7.82M $4.42M
+ Operating Income $-11.05M $-9.84M $-6.80M $-33.63M $-13.52M $-4.63M $-9.27M $-16.18M $-6.51M $-8.29M $5.80M $9.68M $-9.22M
Operating Margin % -4249.2% -1900.0% -318.0% -2262.9% -11752.2% -4453.8% -5265.3% -5152.5% -1518.2% -1791.4% 1952.2% -272.7% -906.7%
Interest Expense $69.00K $45.00K $24.00K $25.00K $17.00K - - - - - - - $24.00K
Other Income/Expense $223.00K $125.00K $157.00K $146.00K $53.00K $110.00K $153.00K $269.00K $-4.00K $-16.00K $-2.00K $-371.00K $62.00K
Income Before Tax - - - - - - $-9.13M $-15.99M $-6.49M $-8.33M $5.96M $9.31M $-9.33M
Income Tax Expense - - - - - - - - - - - - -
+ Net Income $-10.85M $-9.74M $-6.67M $-33.51M $-13.49M $-4.53M $-9.13M $-15.99M $-6.49M $-8.33M $3.03M $-44.98M $-9.33M
Net Margin % -4174.6% -1880.7% -312.0% -2255.1% -11733.0% -4355.8% -5186.9% -5093.0% -1512.6% -1799.8% 1021.2% 1267.0% -917.7%
Basic EPS -0.34 -0.30 -0.26 -2.30 -0.98 -0.36 -1.13 -2.07 -0.81 -1.07 0.02 -0.40 -0.08
Diluted EPS -0.34 -0.30 -0.26 -2.30 -0.98 -0.36 -1.13 -2.07 -0.81 -1.07 0.02 -8.03 nan
Basic Shares Outstanding 32.0M 32.0M 25.7M 1.4M 13.7M 12.9M 8.3M 205K 8K 8K 119.2M -108.0M 118.6M
Diluted Shares Outstanding 32.0M 32.0M 25.7M 1.4M 13.7M 12.9M 8.3M 205K 8K 8K 119.3M 5.5M -
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $18.69M $24.29M $31.03M $8.64M $3.36M $9.26M $5.58M $9.43M $13.78M $17.37M $11.80M $19.99M $32.05M
Accounts Receivable $258.00K $512.00K $3.54M $1.61M $209.00K $85.00K $161.00K $484.00K $1.88M $1.72M $1.90M $2.01M $1.99M
Inventory $471.00K $693.00K $459.00K $410.00K $232.00K - - - - - - - -
Other Current Assets $1.24M $1.35M $1.24M $821.00K $627.00K $595.00K $735.00K $643.00K $672.00K $1.18M $970.00K $977.00K $2.17M
Total Current Assets $21.39M $26.84M $36.26M $11.76M $4.79M $9.97M $6.54M $10.70M $16.92M $20.98M $15.65M $25.54M $36.64M
Goodwill - - - - - - - - - - - - $18.68M
Intangible Assets $14.60M $14.60M $14.60M $14.61M $56.53M $56.55M $56.57M $56.59M $56.62M $56.64M $56.66M $61.63M $88.36M
Other Non-current Assets $672.00K $702.00K $642.00K $691.00K $699.00K $563.00K $438.00K $463.00K $520.00K $329.00K $367.00K $371.00K $366.00K
Total Assets $43.94M $50.52M $60.36M $35.08M $70.22M $74.72M $70.97M $74.89M $81.59M $87.54M $82.80M $100.09M $157.34M
Accounts Payable $1.06M $1.28M $2.28M $2.28M $872.00K $1.05M $908.00K $953.00K $1.14M $875.00K $1.40M $1.25M $1.83M
Accrued Liabilities $2.23M $1.46M $2.52M $1.94M $1.91M $1.31M $2.43M $1.65M $1.72M $1.30M $2.23M $1.77M $4.07M
Total Current Liabilities $7.66M $6.65M $9.68M $7.28M $9.09M $7.20M $8.33M $7.19M $8.03M $7.67M $9.43M $12.11M $12.95M
Total Liabilities $53.13M $49.42M $50.14M $47.35M $60.51M $52.02M $54.05M $49.30M $39.10M $39.22M $39.34M $60.50M $75.41M
Common Stock $368.52M $367.96M $367.39M $338.24M $326.68M $326.20M $310.55M $310.30M $310.00M $309.54M $295.53M $294.93M $292.54M
Retained Earnings $-377.81M $-366.95M $-357.21M $-350.54M $-317.03M $-303.54M $-299.00M $-289.88M $-272.46M $-265.98M $-257.64M $-260.68M $-215.70M
Total Stockholders Equity $-9.20M $1.10M $10.22M $-12.27M $9.71M $22.70M $11.59M $20.47M $37.56M $43.60M $37.93M $34.29M $76.86M
Total Liabilities & Equity $43.94M $50.52M $60.36M $35.08M $70.22M $74.72M $70.97M $74.89M $81.59M $87.54M $82.80M $100.09M $157.34M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-10.85M $-16.41M $-6.67M $-33.51M $-27.15M $-13.66M $-9.13M $-15.99M $-6.49M $-5.30M $3.03M $-44.98M $-9.33M
Depreciation & Amortization $584.00K $559.00K $484.00K $541.00K $318.00K $617.00K $313.00K $303.00K - - - - -
Stock-based Compensation $1.50M $977.00K $473.00K $499.00K $1.25M $804.00K $418.00K $484.00K $2.28M $1.67M $834.00K $2.62M $7.42M
Change in Receivables $-1.35M $-1.10M $1.93M $1.40M $-275.00K $-399.00K $-323.00K $21.00K $-130.00K $-296.00K $-111.00K $22.00K $553.00K
Change in Inventory $61.00K $283.00K $49.00K $178.00K $232.00K - - - - - - - -
Operating Cash Flow $-16.64M $-12.14M $-5.86M $-5.35M $-15.36M $-9.81M $-3.83M $-4.42M $-18.76M $-16.50M $-9.67M $-9.65M $-35.92M
Capital Expenditure $1.71M $656.00K $307.00K $214.00K $302.00K $215.00K $24.00K $264.00K $17.00K - - $802.00K $3.54M
Investing Cash Flow $-1.71M $-656.00K $-307.00K $-210.00K $-302.00K $-215.00K $-24.00K $103.00K $-1.17M $123.00K - $-802.00K $-3.54M
Debt Repayment - - - - - - - - - - - - $1.32M
Stock Issued $29.14M $29.14M $29.14M $10.21M $15.81M $15.81M - - $13.85M $13.85M - - $32.81M
Financing Cash Flow $28.32M $28.44M $28.56M $10.84M $9.59M $9.85M - $-30.00K $12.22M $12.25M $-28.00K $-100.00K $35.91M
Net Change in Cash $9.87M $15.65M $22.39M $5.27M $-6.07M $-176.00K $-3.85M $-4.35M $-7.72M $-4.13M $-9.70M $-10.55M $-3.55M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $260.00K $115.00K $2.92M $395.00K
Cost of Revenue $121.00K $43.00K $1.11M $184.00K
Gross Profit $139.00K $50.00K $1.80M $145.00K
Operating Expenses $11.19M $13.56M $29.49M $27.56M
Research & Development $3.88M $2.82M $10.07M $7.58M
Operating Income $-11.05M $-13.52M $-27.69M $-27.41M
Interest Expense - - $69.00K $17.00K
Other Income/Expense $223.00K $53.00K $505.00K $316.00K
Income Tax Expense - - - -
Net Income $-10.85M $-13.49M $-27.27M $-27.15M
Basic EPS -0.34 -0.98 -0.91 -2.36
Diluted EPS -0.34 -0.98 -0.91 -2.36
Basic Shares Outstanding $32.03M $13.71M $29.94M $11.62M
Diluted Shares Outstanding $32.03M $13.71M $29.94M $11.62M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $18.69M $8.64M
Accounts Receivable $258.00K $1.61M
Inventory $471.00K $410.00K
Other Current Assets $1.24M $821.00K
Total Current Assets $21.39M $11.76M
Intangible Assets $14.60M $14.61M
Other Non-current Assets $672.00K $691.00K
Total Assets $43.94M $35.08M
Accounts Payable $1.06M $2.28M
Accrued Liabilities $2.23M $1.94M
Total Current Liabilities $7.66M $7.28M
Total Liabilities $53.13M $47.35M
Common Stock $368.52M $338.24M
Retained Earnings $-377.81M $-350.54M
Total Stockholders Equity $-9.20M $-12.27M
Total Liabilities & Equity $43.94M $35.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-10.85M $-13.49M $-27.27M $-27.15M
Depreciation & Amortization $584.00K $318.00K $1.63M $935.00K
Stock-based Compensation - - $1.50M $1.25M
Change in Receivables - - $-1.35M $-275.00K
Change in Inventory - - $61.00K $232.00K
Operating Cash Flow - - $-16.64M $-15.34M
Capital Expenditure - - $1.71M $302.00K
Investing Cash Flow - - $-1.71M $-302.00K
Stock Issued - - $29.14M $15.81M
Financing Cash Flow - - $28.32M $9.59M
Net Change in Cash - - $9.87M $-6.07M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...